Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-20 | 2024-06 | 0 | N/A | N/A | N/A |
2024-07-01 | 2024-03 | 0 | N/A | N/A | N/A |
2023-02-28 | 2022-12 | -0.19 | N/A | N/A | N/A |
2022-11-08 | 2022-09 | -0.25 | -0.2 | 0.05 | 20.00% |
2022-08-15 | 2022-06 | -0.23 | -0.31 | -0.08 | -34.78% |
2022-05-05 | 2022-03 | 0 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2022-11-02 | Cantor Fitzgerald | Upgrade | Overweight | |
2022-03-25 | HC Wainwright & Co. | Upgrade | Buy | |
2021-08-09 | HC Wainwright & Co. | Upgrade | Buy | |
2021-01-21 | Alliance Global Partners | Upgrade | Buy | |
2020-07-31 | HC Wainwright & Co. | Upgrade | Buy | |
2020-05-26 | Dawson James | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2018-09-12 | ABG MANAGEMENT, LTD. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2021-03-15 | ASGHAR NAJJAM | Chief Financial Officer | 56.97K | Stock Award(Grant) |
2018-01-23 | ASIA PACIFIC MEDTECH BVI, LTD. | Beneficial Owner of more than 10% of a Class of Security | 8.62M | Sale |
2020-12-15 | FOLLOWWILL DORMAN | Director | 2.13K | Sale |
2021-12-26 | JANDA KIM D | Director | 3.00K | Sale |
2022-12-20 | JI HENRY H | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | State Street Corporation | 50.64M | 15.56M | 10.73% |
2022-12-30 | Blackrock Inc. | 39.42M | 12.11M | 8.35% |
2022-12-30 | Vanguard Group, Inc. (The) | 29.54M | 9.08M | 6.26% |
2022-12-30 | Geode Capital Management, LLC | 8.91M | 2.74M | 1.89% |
2022-12-30 | B. Riley Financial, Inc. | 5.22M | 1.60M | 1.11% |
2022-12-30 | B. Riley Securities, Inc. | 5.22M | 1.60M | 1.11% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 40.89M | 12.56M | 8.66% |
2022-09-29 | Vanguard Total Stock Market Index Fund | 12.84M | 3.95M | 2.72% |
2022-12-30 | iShares Russell 2000 ETF | 10.36M | 3.18M | 2.20% |
2022-09-29 | Vanguard Extended Market Index Fund | 5.51M | 1.69M | 1.17% |
2022-12-30 | Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 4.27M | 1.31M | 0.91% |
2022-12-30 | iShares Russell 2000 Value ETF | 4.11M | 1.26M | 0.87% |
Split | Date |
---|---|
0.04 : 1 | 2013-08-01 |
0.1 : 1 | 2008-10-07 |
-
-
My son college fund going down the shit River!
-
Highest institution owned to date . If they are buying so am I !!!
Yah baby ! -
Institutions are buying
Went from 26% to almost 30 %!!!
It’s a buy at these cheap prices .
-
This is Sorrento’s year . !!! Big things coming
This ceo is pulling off the biggest short trap / squeeze of all time . He called them out and told longs you be patient!!! Sometime you are going to be confused but he is pulling them in so we can spit them out .!!!!
Go Sorrento therapeutics
-
Love this play
-
I missed Trump market
-
-
-
-
-
Amgen an Sorrento are going to merge. You heard it hear first ! It’s leaking out . Amgen is a poet house in need of a bigger pipeline ! Sorrento has that pipeline ! I live in RHODE island trust me
-
I am glade that it’s not going to brake me
But it’s hurts -
ji so far the only family ruined is the longs !
-
This is the sling shot play !!!!! Trust me !!
Great buy !!!
I am not a Financial advisor -
Loading up on this hidden gem
-
-
This is a company/stock there is going to explode. And when it does people are gonna be like oh my God how come I wasn’t in that. We won’t be saying that my friends that her longs and balls. Rapid Home testing and antibodies treatments are all over the news today. The new year will put pressure on Biden to stock up on test and antibodies ! Risk reward here in opinion is worth it 100%.
If the Navy trust Sorrento to keep their men and women healthy so do I !!!
Let’s go bulls -
All over the news
Rapid test !!!!!!!!Wtf is wrong with the fda????
-
Fox just praised therapeutics. Good time for some pr about ours. Then they went into home rapid test being crucial!